| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $7.43B | -8.9% |
| Cost of Revenue | $5.64B | -12.0% |
| Gross Profit | $1.79B | +2.4% |
| R&D Expense | $67.0M | +6.3% |
| Operating Income | $883.0M | -7.7% |
| Pre-tax Income | $931.0M | +11.0% |
| Income Tax | $277.0M | +47.3% |
| Net Income | $647.0M | +0.6% |
| EPS (Basic) | $9.88 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $997.0M | +148.6% |
| Accounts Receivable | $1.09B | -14.5% |
| Inventory | $1.19B | -18.1% |
| Current Assets | $3.35B | -1.3% |
| Total Assets | $7.44B | -2.6% |
| Current Liabilities | $1.28B | -27.7% |
| Long-term Debt | $1.79B | +2.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.44B | +35.9% |
| Capital Expenditures | $301.0M | -4.7% |
| Investing Cash Flow | -$47.0M | +85.7% |
| Financing Cash Flow | -$765.0M | -34.4% |
| Free Cash Flow | $1.14B | +53.2% |
| +1.4% |
| EPS (Diluted) | $9.71 | +1.1% |
| Total Liabilities |
| $3.55B |
| -11.0% |
| Stockholders' Equity | $3.80B | +7.5% |